← All organizations

Centrexion Therapeutics

For profitWebsite ↗

Also known as: Centrexion Therapeutics | Centrexion Therapeutics Corp

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 31, 2025

Timeline

2010s

Jun 1, 2013
Centrexion Therapeutics— Founded

Drugs by trial phase (5 distinct, 14 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (21)

NCT07122453Lead sponsorPhase 1Aug 31, 2025
NCT04154501Lead sponsorPhase 1Dec 4, 2018
NCT04154501Study chairPhase 1Dec 4, 2018
NCT03661996Study chairPhase 3Sep 30, 2018
NCT03660943Study chairPhase 3Sep 30, 2018
NCT03660943Lead sponsorPhase 3Sep 30, 2018
NCT03661996Lead sponsorPhase 3Sep 30, 2018
NCT03576508Study chairPhase 1Jun 25, 2018
NCT03576508Lead sponsorPhase 1Jun 25, 2018
NCT03472677Lead sponsorPhase 1Mar 21, 2018
NCT03472677Study chairPhase 1Mar 21, 2018
NCT03429049Lead sponsorPhase 3Jan 24, 2018
NCT03429049Study chairPhase 3Jan 24, 2018
NCT03787004Study chairPhase 1Aug 14, 2017
NCT03787004Lead sponsorPhase 1Aug 14, 2017

Details

Founded: Boston, MA, US Jun 1, 2013
Last known activity: Aug 31, 2025